RARLIBY

Serial Number 90287803
Registration 7525939
700

Registration Progress

Application Filed
Oct 29, 2020
Under Examination
Jun 29, 2021
Approved for Publication
May 4, 2021
Published for Opposition
Jul 23, 2024
Registered
Oct 8, 2024

Trademark Image

RARLIBY

Basic Information

Serial Number
90287803
Registration Number
7525939
Filing Date
October 29, 2020
Registration Date
October 8, 2024
Published for Opposition
July 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 8, 2024
Registration
Registered
Classes
005

Rights Holder

Gilead Sciences Ireland UC

99
Address
IDA Business and Technology Park
Carrigtohill, Co. Cork
IE

Ownership History

Gilead Sciences Ireland UC

Original Applicant
99
Carrigtohill, Co. Cork IE

Gilead Sciences Ireland UC

Owner at Publication
99
Carrigtohill, Co. Cork IE

Gilead Sciences Ireland UC

Original Registrant
99
Carrigtohill, Co. Cork IE

Legal Representation

Attorney
Gretchen R. Stroud

USPTO Deadlines

Next Deadline
1898 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-10-08)
Due Date
October 08, 2030
Grace Period Ends
April 08, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Oct 8, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 8, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 17, 2024 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jun 12, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Jun 12, 2024 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Jun 10, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Apr 30, 2024 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Dec 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 30, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 30, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 4, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 4, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
May 4, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 14, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 14, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 7, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 5, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 5, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
May 5, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 25, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 25, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 4, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 4, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 14, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 30, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 29, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 22, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 2, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification

International Classes
005